Costs for semaglutide medicines can vary a lot and may depend on insurance, the specific drug, and where a person lives
The company has already stockpiled over $500 million in pre-launch inventory, signaling confidence in its success
Expanded obesity drug coverage can increase Medicaid spending and put pressure on overall state budgets, and states are now facing tighter budget conditions and longer-term fiscal uncertainty, due in part to the federal Medicaid cuts in the 2025 reconciliation law, causing state Medicaid programs to re-evaluate their obesity drug coverage
Cascade of immune mechanism and consequences of inflammatory disorders
Diabetes Care 44(7):15151523
Due to the increased use of GLP-1 and GIP/GLP-1 receptor agonists in the treatment of T2DM and obesity, paired with increased inappropriate prescribing for weight loss, drug manufactures are simply unable to maintain a supply that is sufficient to meet this increased demand